{"id":"https://openalex.org/W2164728818","doi":null,"title":"Lonidamine in high-risk breast cancer patients.","display_name":"Lonidamine in high-risk breast cancer patients.","publication_year":1991,"publication_date":"1991-04-01","ids":{"openalex":"https://openalex.org/W2164728818","mag":"2164728818","pmid":"https://pubmed.ncbi.nlm.nih.gov/2031199"},"language":"en","primary_location":{"id":"pmid:2031199","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2031199","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110479060","display_name":"Kurt Possinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K Possinger","raw_affiliation_strings":["GSF-Institut f\u00fcr Klinische H\u00e4matologie M\u00fcnchen, Germany","From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSF-Institut f\u00fcr Klinische H\u00e4matologie M\u00fcnchen, Germany","institution_ids":[]},{"raw_affiliation_string":"From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111537581","display_name":"Horst Wagner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H Wagner","raw_affiliation_strings":["From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S Kovacs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S Kovacs","raw_affiliation_strings":["From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050831547","display_name":"B. Flath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"B Flath","raw_affiliation_strings":["From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111984482","display_name":"Susanne Classen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S Classen","raw_affiliation_strings":["From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108534913","display_name":"W. Wilmanns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W Wilmanns","raw_affiliation_strings":["From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Med. Klinik III, Klinikum Gro\u03b2hadern, Universit\u00e4t M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I8204097"],"apc_list":null,"apc_paid":null,"fwci":0.2087,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.44064806,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"2 Suppl 4","first_page":"58","last_page":"61"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.05040000006556511,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lonidamine","display_name":"lonidamine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/high-risk-breast-cancer","display_name":"high-risk breast cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.7039999961853027},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.8330000042915344},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9120000004768372},{"id":"https://openalex.org/keywords/vinca-alkaloids","display_name":"vinca alkaloids","score":0.7059999704360962},{"id":"https://openalex.org/keywords/cellular-energy-metabolism","display_name":"cellular energy metabolism","score":0.7239999771118164},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6069999933242798},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8349999785423279},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.7630000114440918},{"id":"https://openalex.org/keywords/remission-rate","display_name":"remission rate","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9379475116729736},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.7731229066848755},{"id":"https://openalex.org/C2778616394","wikidata":"https://www.wikidata.org/wiki/Q474959","display_name":"myalgia","level":2,"score":0.6873784065246582},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6745789051055908},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6545689702033997},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6195218563079834},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5229609608650208},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4997830390930176},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4940793812274933},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4839370846748352},{"id":"https://openalex.org/C2778670039","wikidata":"https://www.wikidata.org/wiki/Q414004","display_name":"Nitrogen mustard","level":4,"score":0.42375633120536804},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3870706558227539},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36731261014938354},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36347830295562744}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014751","descriptor_name":"Vindesine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014751","descriptor_name":"Vindesine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:2031199","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2031199","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Clinical Trial"},{"id":"pmh:oai:opus-zb.helmholtz-muenchen.de:34137","doi":null,"is_oa":false,"landing_page_url":"https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=34137","pdf_url":null,"source":{"id":"https://openalex.org/S4377196115","display_name":"Site cant be reached","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Semin. Oncol. 18, 58-61 (1991)","raw_type":"article"},{"id":"mag:2164728818","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2031199","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W1836115940"],"related_works":["https://openalex.org/W1880268919","https://openalex.org/W2992566835","https://openalex.org/W2049683923","https://openalex.org/W2038920409","https://openalex.org/W2412320538","https://openalex.org/W2118241048","https://openalex.org/W2006350488","https://openalex.org/W2015471089","https://openalex.org/W2063071819","https://openalex.org/W2415798357"],"abstract_inverted_index":{"Lonidamine":[0],"revealed":[1],"synergistic":[2],"effects":[3],"with":[4,39,135,217],"anthracyclines":[5],"and":[6,24,59,129,213],"alkylating":[7],"agents":[8],"in":[9,44,57,132,214,232],"experimental":[10],"investigations.":[11],"It":[12],"differs":[13],"from":[14],"conventional":[15],"cytostatics":[16],"by":[17,55],"acting":[18],"on":[19],"the":[20,47,195,198],"cell":[21],"energy":[22],"metabolism":[23],"also":[25],"lacks":[26],"their":[27],"typical":[28],"side":[29],"effects;":[30],"therefore":[31],"it":[32],"may":[33,52],"be":[34,37,53,244],"valuable":[35],"to":[36,80,94,110,117,126,225,239],"combined":[38],"established":[40],"chemotherapeutic":[41],"regimens.":[42],"Because":[43],"unselected":[45],"patients":[46,133,162,174,180,215],"results":[48],"of":[49,61,87,160,194,197,223],"randomized":[50],"studies":[51],"influenced":[54],"differences":[56],"type":[58],"combination":[60],"prognostic":[62],"factors,":[63],"we":[64],"defined":[65],"strict":[66],"entry":[67],"criteria:":[68],"no":[69,96,200],"previous":[70],"systemic":[71],"palliative":[72],"treatment,":[73],"disease-free":[74],"interval":[75,202],"less":[76,90,106,113],"than":[77,91,107,114],"or":[78,92,98,108,115,235],"equal":[79,93,109,116],"2":[81,179],"years,":[82],"measurable":[83],"visceral":[84],"metastases,":[85,100],"number":[86],"tumor":[88,182],"sites":[89],"2,":[95,111],"brain":[97],"bone":[99],"World":[101],"Health":[102],"Organization":[103],"performance":[104],"status":[105],"age":[112],"55.":[118],"In":[119,192],"an":[120,164],"ongoing":[121],"rate,":[122],"remission":[123,166,233,236],"duration,":[124],"time":[125,131],"treatment":[127,201],"failure,":[128],"survival":[130],"treated":[134,216],"vindesin":[136],"3":[137,152],"mg/m2":[138,142,146],"plus":[139,143],"epirubicin":[140],"100":[141],"cyclophosphamide":[144],"600":[145,156],"(day":[147],"1,":[148],"intravenous,":[149],"repeated":[150],"every":[151],"weeks)":[153],"+/-":[154],"lonidamine":[155,224,240],"mg/day":[157],"orally.":[158],"Eight":[159],"12":[161],"achieved":[163],"objective":[165],"(complete":[167],"response":[168,171],"4,":[169],"partial":[170],"4),":[172],"1":[173,184],"had":[175],"a":[176],"stable":[177],"disease,":[178],"experienced":[181],"progression;":[183],"patient":[185],"is":[186],"not":[187,228,242],"yet":[188,243],"evaluable":[189],"for":[190],"response.":[191],"spite":[193],"intensity":[196],"therapy":[199],"prolongation":[203],"was":[204],"necessary.":[205],"Main":[206],"toxicities":[207],"were":[208],"myelosuppression,":[209],"nausea,":[210],"emesis,":[211],"alopecia,":[212],"lonidamine,":[218],"mild":[219],"myalgia.":[220],"The":[221],"addition":[222],"polychemotherapy":[226],"did":[227],"affect":[229],"myelosuppression.":[230],"Differences":[231],"rates":[234],"duration":[237],"due":[238],"could":[241],"demonstrated.":[245]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}